A High-Efficiency HeLa Cell Nuclear Transcription Extract
David J. Shapiro, Phillip A. Sharp, Walter Wahli et al. · DNA · 1988
A HeLa cell nuclear transcription extract that is approximately 20 times more efficient than standard HeLa cell transcription extracts was developed. Transcription of the strong adenovirus II major late promoter by this extract results in the synthesis of 1.5-4 molecules of product RNA per molecule of template, indicating that the extract is capable of multiple rounds of initiation. Standard HeLa cell nuclear extracts transcribe closed circular and linear adenovirus major late promoter templates with equal efficiency. In contrast, the new extract exhibits an increase of approximately twofold on transcription of a closed circular, as opposed to a linear, major late promoter template.
Cited by 577 works. doi:10.1089/dna.1988.7.47
Authors
References
- Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
- DNA-dependent transcription of adenovirus genes in a soluble whole-cell extract.
- Selective and accurate initiation of transcription at the ad2 major late promotor in a soluble system dependent on purified rna polymerase ii and dna
- Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region
- Normal and mutant human β-globin pre-mRNAs are faithfully and efficiently spliced in vitro
- A Drosophila RNA polymerase II transcription factor contains a promoter-region-specific DNA-binding activity
- Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay.
- Separation and characterization of factors mediating accurate transcription by RNA polymerase II.
- Sequences upstream from the T-A-T-A box are required in vivo and in vitro for efficient transcription from the adenovirus serotype 2 major late promoter.
- Stimulation of in vitro transcription from the SV40 early promoter by the enhancer involves a specific trans‐acting factor.